228 related articles for article (PubMed ID: 6121182)
61. Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase.
Drivsholm L; Vangsted A; Pallesen T; Hansen M; Dombernowsky P; Hirsch F; Hansen HH
Ann Oncol; 1994 Sep; 5(7):623-6. PubMed ID: 7993838
[TBL] [Abstract][Full Text] [Related]
62. Neuron specific enolase: a marker of (small cell) cancers of neuronal and neuroendocrine origin.
Cooper EH
Biomed Pharmacother; 1985; 39(4):165-6. PubMed ID: 2998499
[TBL] [Abstract][Full Text] [Related]
63. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
Zeltzer PM; Marangos PJ; Parma AM; Sather H; Dalton A; Hammond D; Siegel SE; Seeger RC
Lancet; 1983 Aug; 2(8346):361-3. PubMed ID: 6135871
[TBL] [Abstract][Full Text] [Related]
64. Cut-off levels of NSE to differentiate SCLC from NSCLC.
Satoh H; Ishikawa H; Kurishima K; Yamashita YT; Ohtsuka M; Sekizawa K
Oncol Rep; 2002; 9(3):581-3. PubMed ID: 11956631
[TBL] [Abstract][Full Text] [Related]
65. Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenase.
Mall JW; Schwenk W; Philipp AW; Meyer-Kipker C; Mall W; Muller J; Pollmann C
Respirology; 2002 Jun; 7(2):99-102. PubMed ID: 11985730
[TBL] [Abstract][Full Text] [Related]
66. Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer.
Fischbach W; Schwarz-Wallrauch C; Jany B
Cancer; 1989 Mar; 63(6):1143-9. PubMed ID: 2537135
[TBL] [Abstract][Full Text] [Related]
67. Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.
Shimokata K; Niwa Y; Yamamoto M; Sasou H; Morishita M
Chest; 1989 Mar; 95(3):602-3. PubMed ID: 2537710
[TBL] [Abstract][Full Text] [Related]
68. [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer].
Moriya H; Hisa S; Satoh T; Suzuki S; Kimura K; Higuchi Y; Hoshi K
Rinsho Hoshasen; 1988 Jan; 33(1):31-4. PubMed ID: 2835529
[No Abstract] [Full Text] [Related]
69. Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
Br J Cancer; 1992 Sep; 66(3):594-8. PubMed ID: 1325829
[TBL] [Abstract][Full Text] [Related]
70. Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples.
Drivsholm L; Osterlind K; Cooper EH; Purves DA
Int J Biol Markers; 1995; 10(1):1-4. PubMed ID: 7629420
[TBL] [Abstract][Full Text] [Related]
71. [Clinical significance of the measurement of serum neuron-specific enolase levels in patients with lung cancer].
Yumoto Y; Shiota T; Tamai M; Okabe K; Kiura K; Shimoe T; Fujii M
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2089-93. PubMed ID: 3013098
[TBL] [Abstract][Full Text] [Related]
72. Serum neuron-specific enolase as a marker of small-cell carcinoma of the esophagus.
Sasajima K; Watanabe M; Ando T; Hao K; Miyashita M; Yamashita K; Onda M; Takubo K
J Clin Gastroenterol; 1990 Aug; 12(4):384-8. PubMed ID: 2168912
[TBL] [Abstract][Full Text] [Related]
73. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
[TBL] [Abstract][Full Text] [Related]
74. Levels of neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer.
Splinter TA; Carney DN; Teeling M; Oosterom R
J Cancer Res Clin Oncol; 1988; 114(6):641-3. PubMed ID: 2849606
[TBL] [Abstract][Full Text] [Related]
75. Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
Okusaka T; Eguchi K; Kasai T; Kurata T; Yamamoto N; Ohe Y; Tamura T; Shinkai T; Saijo N
Clin Cancer Res; 1997 Jan; 3(1):123-7. PubMed ID: 9815547
[TBL] [Abstract][Full Text] [Related]
76. Serum pseudouridine as a biochemical marker in small cell lung cancer.
Tamura S; Fujioka H; Nakano T; Hada T; Higashino K
Cancer Res; 1987 Nov; 47(22):6138-41. PubMed ID: 2822241
[TBL] [Abstract][Full Text] [Related]
77. Clinical biochemistry of neuron specific enolase.
Kaiser E; Kuzmits R; Pregant P; Burghuber O; Worofka W
Clin Chim Acta; 1989 Jul; 183(1):13-31. PubMed ID: 2548772
[TBL] [Abstract][Full Text] [Related]
78. [Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer and evaluation on the clinical diagnosis efficiency].
Shen D; Han BB; Chen F; Wei BJ; Cui CJ; Wang GJ; Cui W
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2657-2662. PubMed ID: 28910952
[No Abstract] [Full Text] [Related]
79. The value of tumour markers in lung cancer.
Gomm SA; Keevil BG; Thatcher N; Hasleton PS; Swindell RS
Br J Cancer; 1988 Dec; 58(6):797-804. PubMed ID: 2906254
[TBL] [Abstract][Full Text] [Related]
80. [Comparison of the degree of regression of small cell lung neoplasm in clinical-radiologic evaluation with levels of neuron specific enolase (NSE) in serum].
Rowińska-Zakrzewska E; Szturmowicz M; Sakowicz A; Pawlicka L; Remiszewki P; Szopiński J; Wiatr E; Zych J
Pneumonol Alergol Pol; 1995; 63(11-12):601-8. PubMed ID: 8616474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]